Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer
Clinical trial NCT00084565 · WITHDRAWN
Trial details
- NCT number
- NCT00084565
- Sponsor
- Fox Chase Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2004-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.